Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 618 for:    Hemorrhage AND postpartum
Previous Study | Return to List | Next Study

Postpartum Hemorrhage After Shenghua Decoction Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04027920
Recruitment Status : Completed
First Posted : July 22, 2019
Last Update Posted : July 22, 2019
Sponsor:
Information provided by (Responsible Party):
Sheng-Mou Hsiao, Far Eastern Memorial Hospital

Brief Summary:
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment.

Condition or disease Intervention/treatment
Postpartum Hemorrhage Drug: Shenghua Decoction

Detailed Description:
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment.

Layout table for study information
Study Type : Observational
Actual Enrollment : 1 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Disastrous Delayed Postpartum Hemorrhage After Three Days of Shenghua Decoction Treatment: a Case Report
Actual Study Start Date : May 2, 2019
Actual Primary Completion Date : June 17, 2019
Actual Study Completion Date : June 17, 2019

Resource links provided by the National Library of Medicine



Intervention Details:
  • Drug: Shenghua Decoction
    Three days' shenghua decoction treatment


Primary Outcome Measures :
  1. Presence of postpartum hemorrhage or not [ Time Frame: 1 year ]
    Presence of postpartum hemorrhage or not, following three days of shenghua decoction treatment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A postpartum woman with delayed pospartum hemorrhage
Criteria

Inclusion Criteria:

  • Postpartum hemorrhage after shenghua decoction treatment.

Exclusion Criteria:

  • Nil

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04027920


Locations
Layout table for location information
Taiwan
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao, New Taipei, Taiwan, 22050
Sponsors and Collaborators
Far Eastern Memorial Hospital

Layout table for additonal information
Responsible Party: Sheng-Mou Hsiao, Chief, Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT04027920     History of Changes
Other Study ID Numbers: 108046-C
First Posted: July 22, 2019    Key Record Dates
Last Update Posted: July 22, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Sheng-Mou Hsiao, Far Eastern Memorial Hospital:
postpartum hemorrhage

Additional relevant MeSH terms:
Layout table for MeSH terms
Hemorrhage
Postpartum Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Puerperal Disorders
Uterine Hemorrhage